Annual Revenue
$802.00 K
-$43.90 M-98.21%
31 December 2023
Summary:
Barinthus Biotherapeutics annual revenue is currently $802.00 thousand, with the most recent change of -$43.90 million (-98.21%) on 31 December 2023. During the last 3 years, it has fallen by -$4.02 million (-83.36%). BRNS annual revenue is now -98.21% below its all-time high of $44.70 million, reached on 31 December 2022.BRNS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$14.97 M
0.00%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly revenue is currently $14.97 millionBRNS quarterly revenue is now -12.27% below its all-time high of $17.06 million, reached on 01 June 2022.BRNS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$14.97 M
0.00%
30 September 2024
Summary:
Barinthus Biotherapeutics TTM revenue is currently $14.97 millionBRNS TTM revenue is now -66.51% below its all-time high of $44.70 million, reached on 31 December 2022.BRNS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -98.2% | - | - |
3 y3 years | -83.4% | +10000.0% | +2302.7% |
5 y5 years | - | - | - |
BRNS Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -98.2% | +199.3% | -12.3% | >+9999.0% | -66.5% | +5485.4% |
5 y | 5 years | -98.2% | +199.3% | -12.3% | >+9999.0% | -66.5% | +5485.4% |
alltime | all time | -98.2% | +199.3% | -12.3% | >+9999.0% | -66.5% | +5485.4% |
Barinthus Biotherapeutics Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $14.97 M(+4381.7%) | $14.97 M(+11.5%) |
Dec 2023 | $802.00 K(-98.2%) | - | - |
June 2023 | - | $334.00 K(-28.6%) | $13.42 M(-55.5%) |
Mar 2023 | - | $468.00 K(-92.8%) | $30.15 M(-32.5%) |
Dec 2022 | $44.70 M(>+9900.0%) | $6.46 M(+4.7%) | $44.70 M(+16.9%) |
Sept 2022 | - | $6.17 M(-63.9%) | $38.24 M(+19.1%) |
June 2022 | - | $17.06 M(+13.6%) | $32.10 M(+113.0%) |
Mar 2022 | - | $15.02 M | $15.07 M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $268.00 K(-94.4%) | - | - |
Dec 2021 | - | -$1000.00(-105.3%) | $268.00 K(-57.0%) |
Sept 2021 | - | $19.00 K(-45.7%) | $623.00 K(-83.8%) |
June 2021 | - | $35.00 K(-83.7%) | $3.85 M(-11.0%) |
Mar 2021 | - | $215.00 K(-39.3%) | $4.33 M(-10.2%) |
Dec 2020 | $4.82 M | $354.00 K(-89.1%) | $4.82 M(+7.9%) |
Sept 2020 | - | $3.25 M(+536.2%) | $4.47 M(+267.4%) |
June 2020 | - | $511.00 K(-27.5%) | $1.22 M(+72.5%) |
Mar 2020 | - | $705.00 K | $705.00 K |
FAQ
- What is Barinthus Biotherapeutics annual revenue?
- What is the all time high annual revenue for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual revenue year-on-year change?
- What is Barinthus Biotherapeutics quarterly revenue?
- What is the all time high quarterly revenue for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM revenue?
- What is the all time high TTM revenue for Barinthus Biotherapeutics?
What is Barinthus Biotherapeutics annual revenue?
The current annual revenue of BRNS is $802.00 K
What is the all time high annual revenue for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual revenue is $44.70 M
What is Barinthus Biotherapeutics annual revenue year-on-year change?
Over the past year, BRNS annual revenue has changed by -$43.90 M (-98.21%)
What is Barinthus Biotherapeutics quarterly revenue?
The current quarterly revenue of BRNS is $14.97 M
What is the all time high quarterly revenue for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly revenue is $17.06 M
What is Barinthus Biotherapeutics TTM revenue?
The current TTM revenue of BRNS is $14.97 M
What is the all time high TTM revenue for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM revenue is $44.70 M